Cargando…
PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis
Programmed cell death ligand 1(PDL-1) is known for its inhibitory effect on the cellular immune response. Even though it is expressed on the surface of mast cells, its role in allergic diseases is unknown. We analyzed the effects of PD-L1 blockade in a murine model of active cutaneous anaphylaxis (A...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100332/ https://www.ncbi.nlm.nih.gov/pubmed/33968057 http://dx.doi.org/10.3389/fimmu.2021.655958 |
_version_ | 1783688764125609984 |
---|---|
author | Bonamichi-Santos, Rafael Aun, Marcelo Vivolo Kalil, Jorge Castells, Mariana Concepcion Giavina-Bianchi, Pedro |
author_facet | Bonamichi-Santos, Rafael Aun, Marcelo Vivolo Kalil, Jorge Castells, Mariana Concepcion Giavina-Bianchi, Pedro |
author_sort | Bonamichi-Santos, Rafael |
collection | PubMed |
description | Programmed cell death ligand 1(PDL-1) is known for its inhibitory effect on the cellular immune response. Even though it is expressed on the surface of mast cells, its role in allergic diseases is unknown. We analyzed the effects of PD-L1 blockade in a murine model of active cutaneous anaphylaxis (ACA). C57BL/6 mice were sensitized and challenged with ovalbumin (OVA). Blood samples were collected to measure specific immunoglobulins. The mice were divided into six groups that underwent the active cutaneous anaphylaxis procedure. Group 1 (negative control) received 50 μl of phosphate-buffered saline (PBS) subcutaneously, and the other five groups were sensitized with 50 μg of OVA subcutaneously. Group 2 was the positive control, and the others received the anti-PD-L1 antibody or its isotype during sensitization (groups 3 and 4) or during the challenge (groups 5 and 6). All animals that underwent ACA on the ears with OVA and PBS were sacrificed, and the reaction was evaluated by extravasation of Evans blue (measured by spectrophotometry) and histological analysis of the collected fragments. Anti-PD-L1 blockade during the sensitization phase led to a reduction in specific IgE and IgG1 levels, allergic reaction intensity at the ACA site, and mast cell degranulation in the tissue. There was no significant biological effect of anti-PD-L1 administration on the challenge phase. PD-L1 blockade during allergen sensitization inhibited the synthesis of specific IgE and IgG1 and decreased mast cell activation in this murine model of anaphylaxis. |
format | Online Article Text |
id | pubmed-8100332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81003322021-05-07 PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis Bonamichi-Santos, Rafael Aun, Marcelo Vivolo Kalil, Jorge Castells, Mariana Concepcion Giavina-Bianchi, Pedro Front Immunol Immunology Programmed cell death ligand 1(PDL-1) is known for its inhibitory effect on the cellular immune response. Even though it is expressed on the surface of mast cells, its role in allergic diseases is unknown. We analyzed the effects of PD-L1 blockade in a murine model of active cutaneous anaphylaxis (ACA). C57BL/6 mice were sensitized and challenged with ovalbumin (OVA). Blood samples were collected to measure specific immunoglobulins. The mice were divided into six groups that underwent the active cutaneous anaphylaxis procedure. Group 1 (negative control) received 50 μl of phosphate-buffered saline (PBS) subcutaneously, and the other five groups were sensitized with 50 μg of OVA subcutaneously. Group 2 was the positive control, and the others received the anti-PD-L1 antibody or its isotype during sensitization (groups 3 and 4) or during the challenge (groups 5 and 6). All animals that underwent ACA on the ears with OVA and PBS were sacrificed, and the reaction was evaluated by extravasation of Evans blue (measured by spectrophotometry) and histological analysis of the collected fragments. Anti-PD-L1 blockade during the sensitization phase led to a reduction in specific IgE and IgG1 levels, allergic reaction intensity at the ACA site, and mast cell degranulation in the tissue. There was no significant biological effect of anti-PD-L1 administration on the challenge phase. PD-L1 blockade during allergen sensitization inhibited the synthesis of specific IgE and IgG1 and decreased mast cell activation in this murine model of anaphylaxis. Frontiers Media S.A. 2021-04-22 /pmc/articles/PMC8100332/ /pubmed/33968057 http://dx.doi.org/10.3389/fimmu.2021.655958 Text en Copyright © 2021 Bonamichi-Santos, Aun, Kalil, Castells and Giavina-Bianchi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bonamichi-Santos, Rafael Aun, Marcelo Vivolo Kalil, Jorge Castells, Mariana Concepcion Giavina-Bianchi, Pedro PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis |
title | PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis |
title_full | PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis |
title_fullStr | PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis |
title_full_unstemmed | PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis |
title_short | PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis |
title_sort | pd-l1 blockade during allergen sensitization inhibits the synthesis of specific antibodies and decreases mast cell activation in a murine model of active cutaneous anaphylaxis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100332/ https://www.ncbi.nlm.nih.gov/pubmed/33968057 http://dx.doi.org/10.3389/fimmu.2021.655958 |
work_keys_str_mv | AT bonamichisantosrafael pdl1blockadeduringallergensensitizationinhibitsthesynthesisofspecificantibodiesanddecreasesmastcellactivationinamurinemodelofactivecutaneousanaphylaxis AT aunmarcelovivolo pdl1blockadeduringallergensensitizationinhibitsthesynthesisofspecificantibodiesanddecreasesmastcellactivationinamurinemodelofactivecutaneousanaphylaxis AT kaliljorge pdl1blockadeduringallergensensitizationinhibitsthesynthesisofspecificantibodiesanddecreasesmastcellactivationinamurinemodelofactivecutaneousanaphylaxis AT castellsmarianaconcepcion pdl1blockadeduringallergensensitizationinhibitsthesynthesisofspecificantibodiesanddecreasesmastcellactivationinamurinemodelofactivecutaneousanaphylaxis AT giavinabianchipedro pdl1blockadeduringallergensensitizationinhibitsthesynthesisofspecificantibodiesanddecreasesmastcellactivationinamurinemodelofactivecutaneousanaphylaxis |